An Evaluation of Quality of Life Outcomes in Cancer Patients Receiving Home Parenteral
18 Years
N/A
Both
Cancer
Trial Information
An Evaluation of Quality of Life Outcomes in Cancer Patients Receiving Home Parenteral
This is a prospective descriptive non-randomized clinical study to examine quality of life
outcomes and use of pain and anti-emetic therapy for patients receiving HPN support. The
EORTC QLQ-C30 will be used to evaluate quality of life. All subjects will be monitored
monthly throughout the course of treatment for a minimum of 3 months and a maximum of 1
year.
Inclusion Criteria:
- Patients with a cancer diagnosis who have been receiving parenteral nutrition in the
hospital or have started on HPN while at Cancer Treatment Centers of America and meet
the criteria for home parenteral nutrition.
- Patient expected to have a life expectancy of greater than 90 days post discharge.
Exclusion Criteria:
- Patients less than 18 years of age
- HPN patients who do not receive nutrition assessment and follow-up by the Coram
Healthcare nutrition support team
- Refuse to participate
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Quality of Life
Outcome Description:
To examine the effect of parenteral nutrition support in the home care setting on quality of life as measured by the EORTC QLQ-C30
Outcome Time Frame:
Monthly for a minimum of 3 months to a maximum of 12 months
Safety Issue:
No
Principal Investigator
Ross Taylor, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Cancer Treatment Centers of America at Southwestern Regional Medical Center
Authority:
United States: Institutional Review Board
Study ID:
SRMC 10-03
NCT ID:
NCT01152879
Start Date:
May 2010
Completion Date:
May 2015
Related Keywords:
- Cancer
- Parenteral Nutrition
- Quality of Life
Name | Location |
|---|---|
| Cancer Treatment Centers of America at Southwestern Regional Medical Center | Tulsa, Oklahoma 74133-4564 |
